Synonyms: NRP104 | Vyvanse®
lisdexamfetamine is an approved drug (FDA (2007))
Compound class:
Synthetic organic
Comment: This drug is a prodrug of dexamphetamine. The amphetamine is released more slowly from this prodrug than by administering active amphetamine directly.
|
|
Bioactivity Comments |
We have been unable to find publicly available affinity data for this drug at its proposed molecular target(s) to substantiate its MMOA, and have therefore not tagged a primary drug target. |